Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-27

Clinical Trial Update: Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A, Zilbrix™ Hib and Polio Sabin™ [Phase 3]

View source ↗

Summary

Phase 3 trial assessing primary vaccination course in children receiving pneumococcal vaccine GSK 1024850A, Zilbrix Hib, and Sabin polio; study completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 1024850A
  • Sabin Polio (Poliovirus vaccine, Sabin strain)
  • Zilbrix Hib (Haemophilus influenzae type b vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Streptococcal | Phase 3 | Status: COMPLETED | Results posted: 2017-10-27